New data from Phase III study showed that people with HER2-positive metastatic breast cancer lived longer with Perjeta
22 June 2012 | By Roche
“We are pleased that Perjeta helped people with HER2-positive metastatic breast cancer..."
List view / Grid view
News
Novartis receives positive CHMP opinion for once-daily Seebri® Breezhaler® to treat COPD patients in the EU
22 June 2012 | By Novartis
CHMP has adopted a positive opinion for Seebri® Breezhaler®...
CHMP recommends Novartis drug Afinitor® for EU approval marking major milestone in the treatment of advanced breast cancer
22 June 2012 | By Novartis
Positive opinion for Afinitor® tablets...
Zinforo receives positive CHMP opinion in the European Union for the treatment of patients with serious skin infections or community acquired pneumonia
22 June 2012 | By AstraZeneca
Zinforo receives positive CHMP opinion...
Bristol-Myers Squibb and Emory University announce partnership
21 June 2012 | By Bristol-Myers Squibb Company
First studies under the agreement to focus on clinical trial programs in oncology...
Catalent and Bend Research partner to provide integrated solutions for oral controlled-release technologies
21 June 2012 | By Catalent Pharma Solutions
Catalent Pharma Solutions and Bend Research have entered into an agreement...
Glythera relocates to North East as part of £2M funding round
21 June 2012 | By kdm communications limited
Glythera has secured a fundraising round totalling £2M with IP Group, which will be tranched over the next three years...
Novo Nordisk to initiate phase 3 development of semaglutide
21 June 2012 | By Novo Nordisk
The decision to initiate the global phase 3 development programme for semaglutide announced...
Novo Nordisk puts health on the agenda in Rio
20 June 2012 | By Novo Nordisk
Novo Nordisk is hosting a side-event during the UN conference, Rio+20, on sustainable development...
First study to evaluate alternative to warfarin for mechanical heart valve patients launched with Pradaxa® (dabigatran etexilate)
20 June 2012 | By Boehringer Ingelheim
The design of the RE-ALIGN study published...
Merck statement on CDC Advisory Committee on Immunization Practices’ recommendation for pneumococcal vaccination
20 June 2012 | By Merck
Merck provided the following statement...
AstraZeneca completes acquisition of Ardea Biosciences
20 June 2012 | By AstraZeneca
AstraZeneca has completed its acquisition of San Diego, California-based biotechnology company Ardea Biosciences, Inc...
Pfizer statement regarding Prevnar 13® receiving ACIP recommendation for prevention of pneumococcal disease
20 June 2012 | By Pfizer
Pfizer issued the following statement...
Roche and Seaside Therapeutics announce landmark alliance to advance novel treatments for FXS and ASD
19 June 2012 | By Roche
Roche and Seaside Therapeutics have entered into a collaboration...
Positive results from Phase 3 study PROFILE 1007 evaluating XALKORI® (crizotinib) in previously treated patients with ALK-Positive advanced NSCLC
19 June 2012 | By Pfizer
Detailed study results to be presented...
